• July 29, 2013 | Bloomberg

    Santander surprise CEO Javier Marin bids for investor trust

    The 46-year-old chief executive officer tomorrow will present his first quarterly earnings report since taking over in April, giving shareholders their closest look yet at how he plans to sh

    1 minute read

  • June 27, 2013 | The American Lawyer

    Big Deals

    Valeant/Bausch & Lomb Valeant Pharmaceuticals International Inc. agreed to pay $8.7 billion in cash for Bausch & Lomb Holdings Inc

    1 minute read